In the past two months alone, Wall Street investors have pumped billions into a handful of biotech companies in the early stages of producing vaccines or drugs to combat the novel coronavirus. The result: a coronavirus investment bubble that's already approaching nearly $200 billion in stock market value.
Trending:
Coronavirus stokes $200B stock market bubble in vaccines